Provided by Tiger Fintech (Singapore) Pte. Ltd.

Atara Biotherapeutics

7.42
+0.10001.37%
Post-market: 7.420.00000.00%16:06 EDT
Volume:30.55K
Turnover:224.53K
Market Cap:43.47M
PE:-0.65
High:7.50
Open:7.38
Low:7.13
Close:7.32
Loading ...
Aug 08, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Jul 29, 2019

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Jul 22, 2019

Major Issues Report

Current report, items 2.02, 8.01, and 9.01
Jul 01, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jul 01, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jul 01, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jul 01, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jul 01, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jul 01, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 28, 2019

Major Issues Report

Current report, item 5.07
Jun 25, 2019

Statement Of Changes In Beneficial Ownership

Initial statement of beneficial ownership of securities
Jun 25, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 05, 2019

Major Issues Report

Current report, item 8.01
May 31, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
May 28, 2019

Major Issues Report

Current report, items 5.02 and 9.01
May 09, 2019

Major Issues Report

Current report, items 2.02 and 9.01
May 09, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Jan 03, 2018

[Supp]Public Prospectus

Atara Biotherapeutics公司。
Nov 19, 2015

Correspondence

Nov 19, 2015

Correspondence

与美国证券交易委员会(SEC)的通信